Thomas J. Schuetz, CEO of Compass Therapeutics ($CMPX), made one open market purchase of company shares in the past year, totaling $21,100. His most recent buy occurred on May 27, 2025. Among 4,983 insiders tracking open market buys, Schuetz ranks 3,777th by purchase value, well below the average of $1.5 million across 3.3 transactions. He reported no open market sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 8, 2026 | Compass Therapeutics, Inc. | $CMPX | Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | F | Common Stock | 36687 | $6.52 | 6,603,336.0000 | 177,862,102 | 0.55% | 0.02% |
| Jan. 9, 2026 | Compass Therapeutics, Inc. | $CMPX | Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | F | Common Stock | 46777 | $5.35 | 6,640,023.0000 | 177,862,102 | 0.70% | 0.03% |
| Jan. 2, 2026 | Compass Therapeutics, Inc. | $CMPX | Schuetz Thomas J. | CEO | A | Stock Option (Right to Buy) | 2000000 | $0.00 | 2,000,000.0000 | 177,862,102 | 9999.99% | 1.12% |
| Jan. 2, 2026 | Compass Therapeutics, Inc. | $CMPX | Schuetz Thomas J. | CEO | A | Common Stock | 250000 | $5.17 | 6,686,800.0000 | 177,862,102 | 3.88% | 0.14% |
| Nov. 16, 2025 | Compass Therapeutics, Inc. | $CMPX | Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | F | Common Stock | 44025 | $4.83 | 6,436,800.0000 | 177,862,102 | 0.68% | 0.02% |
| May 27, 2025 | Compass Therapeutics, Inc. | $CMPX | Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | P | Common Stock | 10000 | $2.11 | 6,480,825.0000 | 138,282,498 | 0.15% | 0.01% |
| Feb. 11, 2025 | Compass Therapeutics, Inc. | $CMPX | Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | A | Stock Option (Right to Buy) | 1500000 | $0.00 | 1,500,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 8, 2025 | Compass Therapeutics, Inc. | $CMPX | Schuetz Thomas J. | CEO | F | Common Stock | 41687 | $3.50 | 6,470,825.0000 | 0 | 0.64% | 0.00% |
| Jan. 9, 2025 | Compass Therapeutics, Inc. | $CMPX | Schuetz Thomas J. | CEO | F | Common Stock | 58054 | $1.86 | 6,512,512.0000 | 0 | 0.88% | 0.00% |
| Feb. 8, 2024 | Compass Therapeutics, Inc. | $CMPX | Schuetz Thomas J. | PRESIDENT | F | Common Stock | 44782 | $1.45 | 6,570,566.0000 | 0 | 0.68% | 0.00% |
| Jan. 9, 2024 | Compass Therapeutics, Inc. | $CMPX | Schuetz Thomas J. | President of R&D | A | Stock Option (Right to Buy) | 637500 | $0.00 | 637,500.0000 | 0 | 9999.99% | 0.00% |
| Jan. 9, 2024 | Compass Therapeutics, Inc. | $CMPX | Schuetz Thomas J. | President of R&D | A | Common Stock | 637500 | $1.93 | 6,615,348.0000 | 0 | 10.66% | 0.00% |
| Nov. 17, 2023 | Compass Therapeutics, Inc. | $CMPX | Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | F | Common Stock | 44025 | $1.50 | 5,977,848.0000 | 0 | 0.73% | 0.00% |
| March 10, 2023 | Compass Therapeutics, Inc. | $CMPX | Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | P | Common Stock | 10000 | $3.37 | 6,021,873.0000 | 0 | 0.17% | 0.00% |
| Feb. 27, 2023 | Compass Therapeutics, Inc. | $CMPX | Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | P | Common Stock | 20000 | $3.98 | 6,011,873.0000 | 0 | 0.33% | 0.00% |
| Feb. 15, 2023 | Compass Therapeutics, Inc. | $CMPX | Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | P | Common Stock | 20000 | $3.86 | 5,991,873.0000 | 0 | 0.33% | 0.00% |
| Feb. 8, 2023 | Compass Therapeutics, Inc. | $CMPX | Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | A | Common Stock | 500000 | $0.00 | 5,971,873.0000 | 0 | 9.14% | 0.00% |
| Feb. 8, 2023 | Compass Therapeutics, Inc. | $CMPX | Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | A | Stock Option (Right to Buy) | 700000 | $0.00 | 700,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 31, 2023 | Compass Therapeutics, Inc. | $CMPX | Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | P | Common Stock | 20000 | $4.05 | 5,471,873.0000 | 0 | 0.37% | 0.00% |
| Jan. 24, 2023 | Compass Therapeutics, Inc. | $CMPX | Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | P | Common Stock | 20000 | $4.19 | 5,451,873.0000 | 0 | 0.37% | 0.00% |